Pfizer and Biontech announced completing Phase 3 for their Covid vaccine on Nov 10, but their stocks showed little progress in November:
2% less than S&P 500 for PFE and 15 % more for BNTX, which, as a small company, should benefit more than that just because of lifting their brand in the spotline.
50 share(s) of your order to Buy 50 share(s) of BGS has been executed at $4.2263.
Leave a comment